6 ePI Implementation Challenges Pharma Companies Must Solve
Why ePI Implementation Challenges Are Increasing ePI is inevitable. Most pharma organizations have accepted that ePI is not optional. According
SmPC to ePI: Navigating ePI Implementation
How pharma teams can prepare for structured product information, FHIR readiness, and EU ePI standards Your organization has spent decades
Structured Content and Data Management (SCDM): Solving Pharma’s Time-to-Market Problem at the Source
Pharma timelines don’t slip because teams are slow, they slip because data is immobile. The regulated information driving global submissions,
AI Won’t Fix Bad Data: Why Data Quality Is the Real Gatekeeper for AI in Pharma
The conversation about data quality for AI in pharma has shifted. It is no longer an upstream IT concern or
Why Regulatory Data Integration in Pharma Matters: Legacy Systems, Governed Data Flow, and the Path to Speed
Digital transformation is not a system problem — it is a data flow problem Digital transformation initiatives often center on
From Compliance to Competitive Advantage: Building a 2026-Ready Regulatory Operating Model in Pharma
2026 Pharma Readiness: Regulatory Readiness Is Now an Enterprise Capability Regulatory readiness has shifted from a supporting function to a
FDA’s 12-Digit NDC Rule: What Labeling Teams Need to Start Planning Now
On March 5, 2026, FDA published a final rule establishing a uniform 12-digit National Drug Code (NDC) format. The rule
How Treating Regulatory Data as an Asset Changes the Economics of Pharma Content
Regulatory Work Is Stuck in a Failing Economic Model Pharmaceutical regulatory operations still run on a linear economic model in
Why Structured Content in Pharma Will Become Essential by 2026
2026 Will Be the Year Structured Content in Pharma Becomes Essential For years, pharma has managed product information through sprawling
How Structured Content is Reshaping eCTD 4.0 & Lifecycle Submissions
Why Regulatory Teams Are Shifting Toward Modular Content in eCTD 4.0 Submissions Traditional document-based processes—where content is authored, reviewed, and
The People Problem: Why Technology Alone Doesn’t Ensure Success
Introduction: Beyond Technology — The Human Side of Content Transformation in Life Sciences Life sciences digital transformation is comprehensive, ongoing
IDMP 2.0: Preparing for the Next Wave of Data Standards
SPOR and IMDP 2.0: Turning Compliance into Competitive Advantage The Identification of Medicinal Products (IDMP) initiative was once viewed as
Digital Twins in Regulatory Affairs: Hype or the Next Submission Era?
Digital Twin Pharma: The Future of Regulatory Submissions? Digital twins have transformed industries such as aerospace, automotive, and manufacturing by
RIM 2025: The Shift Toward Connected, Intelligent, Data-Driven Compliance Powered By Structured Content
Regulatory Information Management 2025: From Repository to Intelligence Hub For years, Regulatory Information Management (RIM) systems have been the quiet
Why Clinical Transformation Will Fail Without Structured Content in Clinical Trials
Key Takeaways The Hidden Obstacle to Digital Transformation in Clinical Trials: Unstructured Content For all the talk about digital transformation
Utilizing AI-Powered Structured Content Authoring for Global ePI Compliance
Future-proof your ePI strategy by combining AI-driven structured content authoring with global regulatory readiness—modular, machine-readable, scalable.